Development of rapidly dissolving pellets within the Quality by Design approach

References

• Gu L, Liew CV, Heng PWS. Wet spheronization by rotary processing – a multistage single-pot process for producing spheroids. Drug Dev Ind Pharm 2004;30:111–23.
   PubMed Web of Science ®Google Scholar
• Ghebre-Sellassie I. Pharmaceutical pelletization technology. New York: Marcel Dekker; 1989.
   Google Scholar
• Abdul S, Chandewar A, Jaiswal SB. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS). J Control Release 2010;147:2–16.
   PubMed Web of Science ®Google Scholar
• Follonier N, Doelker E. Biopharmaceutical comparison of oral multiple unit and single unit sustained release dosage forms. S T P Pharm Sci 1992;2:141–58.
   Google Scholar
• Coupe AJ, Davis SS, Evans DF, Wilding IR. Do pellet formulations empty from the stomach with food? Int J Pharm 1993;9:1–3.
   Google Scholar
• Clarke GM, Newton MJ, Short MD. Gastrointestinal transit of pellets of differing size and density. Int J Pharm 1993;100:81–92.
   Web of Science ®Google Scholar
• Amighi K, Timmermans J, Puigdevall J, et al. Per oral sustained release film coated pellets as a means to overcome physicochemical and biological drug related problems: Part I: In vitro development and evaluation. Drug Dev Ind Pharm 1998;24:509–14.
   PubMed Web of Science ®Google Scholar
• Béchard SR, Leroux JC. Coated pelletized dosage form: effect of comparison on drug release. Drug Dev Ind Pharm 1992;18:1927–44.
   Web of Science ®Google Scholar
• WHO. Report of the informal expert meeting on dosage forms of medicines for children; 2008. Available from: http://www.who.int/selection_medicines/committees/expert/17/application/pediatric/Dosage_form_reportDEC2008.pdf [last accessed 11 Jun 2015].
   Google Scholar
• European Medicines Agency. Reflection paper: formulations of choice for the pediatric population; 2015. Doc Ref EMEA/CHMP/PEG/194810/2005. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003782.pdf [last accessed 12 Jul 2015].
   Google Scholar
• European Medicines Agency. Guideline on pharmaceutical development of medicines for pediatric use; 2015. Doc Ref EMA/CHMP/QWP/805880/2012 Rev. 2, 2014. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf [last accessed 11 Jun 2015].
   Google Scholar
• Haring A, Vetchy D, Janovska L, et al. Differences in characteristics of pellets prepared by different pelletization methods. Drug Dev Ind Pharm 2008;34:289–96.
   PubMed Web of Science ®Google Scholar
• Bouffard J, Dumont H, Bertrand F, Legros R. Optimization and scale up of a fluid bed tangential spray rotorgranulation process. Int J Pharm 1993;335:54–62.
   Web of Science ®Google Scholar
• Alvarez L, Concheiro A, Gomez-Amoza JL, et al. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion–spheronization. Drug Dev Ind Pharm 2002;28:451–6.
   PubMed Web of Science ®Google Scholar
• Dukić-Ott A, Thommes M, Remon JP, et al. Production of pellets via extrusion–spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm 2009;1:38–46.
   Web of Science ®Google Scholar
• European Medicines Agency. ICH guideline Q8 (R2) on pharmaceutical development; 2015. Doc Ref EMEA/CHMP/167068/2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002872.pdf [last accessed 2 Oct 2015].
   Google Scholar
• Ansel HC, Popovich NG, Allen LV Jr. Pharmaceutical dosage forms and drug delivery systems. Vol. 6. New Delhi: B. I. Waverly Pvt. Ltd; 1999:469–71.
   Google Scholar
• Martin A. Physical pharmacy. London: Lea and Febiger; 1993:423–30.
   Google Scholar
• Ericsson M, Alderborn G, Nystrom C, et al. Comparison between and evaluation of some methods for the assessment of the sphericity of pellets. Int J Pharm 1997;148:149–54.
   Web of Science ®Google Scholar
• Leena H, Jouko Y. Process variables of instant granulator and spheronizer. III. Shape and shape distribution of pellets. Int J Pharm 1993;96:217–23.
   Web of Science ®Google Scholar
• Vertommen J, Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution and friability of pellets produced in a rotary processor. Drug Dev Ind Pharm 1997;23:39–46.
   Web of Science ®Google Scholar
• Podczeck F, Newton J. A shape factor to characterize the quality of spheroids. J Pharm Pharmacol 1994;46:82–5.
   PubMed Web of Science ®Google Scholar
• Podczeck F, Newton J. The evaluation of a three-dimensional shape factor for the quantitative assessment of the sphericity and surface roughness of pellets. Int J Pharm 1995;124:253–9.
   Web of Science ®Google Scholar
• Montgomery DC. Design and analysis of experiments. 7th edn. Hoboken (NJ): John Wiley and Sons, Inc.; 2009:289–349.
   Google Scholar
• Obara S, Maruyama N, Nishiyama Y, et al. Dry coating: an innovative enteric coating method using a cellulose derivative. Eur J Pharm Biopharm 1999;47:51–9.
   PubMed Web of Science ®Google Scholar
• Pearnchob N, Bodmeier R. Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique. Int J Pharm 2003;268:1–11.
   PubMed Web of Science ®Google Scholar
• Sauer D, Cerea M, DiNunzio J, et al. Dry powder coating of pharmaceuticals: a review. Int J Pharm 2013;457:488–502.
   PubMed Web of Science ®Google Scholar
• Kablitz CD, Harder K, Urbanetz NA. Dry coating in a rotary fluid bed. Eur J Pharm Sci 2006;27:212–19.
   PubMed Web of Science ®Google Scholar
• Montgomery DC. Design and analysis of experiments. 7th edn. Hoboken (NJ): John Wiley and Sons, Inc.; 2009:207–64.
   Google Scholar
• Myers RH, Montgomery DC, Anderson-Cook CM. Response surface methodology: process and product optimization using designed experiments. 3rd edn. Hoboken (NJ): John Wiley and Sons, Inc.; 2009:219–336.
   Google Scholar
• Lewis G, Mathieu D, Phan-Tan-Luu R. Pharmaceutical experimental design. New York: Markel Dekker; 1999:265–76.
   Google Scholar
• Paterakis PG, Korakianiti ES, Dallas PP, et al. Evaluation and simultaneous optimization of some pellets characteristics using a 33 factorial design and the desirability function. Int J Pharm 2002;248:51–60.
   PubMed Web of Science ®Google Scholar
• Korakianiti ES, Rekkas DM, Dallas PP, et al. Optimization of the pelletization process in a fluid-bed rotor granulator using experimental design. AAPS Pharm Sci Tech 2000;1:E35.
   PubMedGoogle Scholar
• Vertommen J, Jaucot B, Rombaut P, et al. Improvement of the material motion in a rotary processor. Pharm Dev Technol 1996;1:365–71.
   PubMedGoogle Scholar
• Heng P, Wan L, Tan Y. Optimization of spheroid production by centrifugal, rotary processing. Int J Pharm 1996;143:107–12.
   Web of Science ®Google Scholar
• Holm P, Bonde M, Wigmore T. Pelletization by granulation in a roto-processor RP-2. Part I: Effects of process product variables on granule growth. Pharm Tech Eur 1996;8:22–36.
   Google Scholar
• Rambali B, Baert L, Massart DL. Using experimental design to optimize the process parameters in a fluid bed granulation on a semi-full scale. Int J Pharm 2001;220:149–60.
   PubMed Web of Science ®Google Scholar